Breast cancer is the most common type of cancer in women worldwide [1]; approximately 70% of breast cancers are hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2−) [2]. Here, ERBB2 is linked to breast carcinoma.